16.19
0.35 (2.24%)
| Penutupan Terdahulu | 15.83 |
| Buka | 16.00 |
| Jumlah Dagangan | 1,732,704 |
| Purata Dagangan (3B) | 2,390,012 |
| Modal Pasaran | 1,627,515,008 |
| Harga / Jualan (P/S) | 23.01 |
| Harga / Buku (P/B) | 1.56 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2025 |
| Margin Operasi (TTM) | -1,596.87% |
| EPS Cair (TTM) | -4.61 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 0.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.08% |
| Nisbah Semasa (MRQ) | 8.81 |
| Aliran Tunai Operasi (OCF TTM) | -351.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -185.90 M |
| Pulangan Atas Aset (ROA TTM) | -19.05% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Beam Therapeutics Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.0 |
| Purata | 1.13 |
|
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.22% |
| % Dimiliki oleh Institusi | 98.14% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Mwg Management Ltd. | 31 Mar 2025 | 2,266,934 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 80.00 (HC Wainwright & Co., 394.29%) | Beli |
| Median | 55.00 (239.82%) | |
| Rendah | 25.00 (Barclays, 54.46%) | Pegang |
| Purata | 54.40 (236.11%) | |
| Jumlah | 4 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 17.24 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 07 May 2025 | 25.00 (54.46%) | Pegang | 16.23 |
| Guggenheim | 07 May 2025 | 55.00 (239.82%) | Beli | 16.23 |
| Wells Fargo | 07 May 2025 | 70.00 (332.50%) | Beli | 16.23 |
| HC Wainwright & Co. | 07 Apr 2025 | 80.00 (394.28%) | Beli | 15.30 |
| B of A Securities | 28 Mar 2025 | 42.00 (159.50%) | Beli | 22.21 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |